TCA
LLY icon

Transcend Capital Advisors’s Eli Lilly LLY Stock Holding History

Transcend Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.37M Sell
6,930
-2,353
-25% -$2.39M 0.51% 38
2025
Q4 		$9.98M Sell
9,283
-1,893
-17% -$1.81M 0.77% 26
2025
Q3 		$8.53M Buy
11,176
+417
+4% +$310K 0.6% 36
2025
Q2 		$8.39M Sell
10,759
-7,279
-40% -$5.66M 0.65% 32
2025
Q1 		$14.9M Buy
18,038
+703
+4% +$585K 1.07% 14
2024
Q4 		$13.4M Buy
17,335
+797
+5% +$660K 0.97% 16
2024
Q3 		$14.7M Sell
16,538
-393
-2% -$353K 0.98% 16
2024
Q2 		$15.3M Buy
16,931
+1,518
+10% +$1.21M 1.11% 12
2024
Q1 		$12M Buy
15,413
+632
+4% +$450K 0.96% 16
2023
Q4 		$8.62M Buy
14,781
+336
+2% +$196K 0.76% 25
2023
Q3 		$7.76M Sell
14,445
-760
-5% -$392K 0.76% 26
2023
Q2 		$7.13M Buy
15,205
+344
+2% +$144K 0.68% 28
2023
Q1 		$5.1M Buy
14,861
+852
+6% +$287K 0.53% 37
2022
Q4 		$5.13M Buy
14,009
+548
+4% +$194K 0.56% 36
2022
Q3 		$4.35M Sell
13,461
-83
-0.6% -$26.3K 0.48% 43
2022
Q2 		$4.39M Sell
13,544
-51
-0.4% -$15.3K 0.46% 44
2022
Q1 		$3.89M Sell
13,595
-62
-0.5% -$16K 0.35% 67
2021
Q4 		$3.77M Buy
13,657
+318
+2% +$80.6K 0.33% 79
2021
Q3 		$3.31M Buy
13,339
+1,156
+9% +$285K 0.3% 87
2021
Q2 		$2.8M Buy
12,183
+5,192
+74% +$1.04M 0.4% 67
2021
Q1 		$1.3M Sell
6,991
-240
-3% -$46.9K 0.16% 145
2020
Q4 		$1.22M Buy
+7,231
New +$1.08M 0.16% 142

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Transcend Capital Advisors's LLY Position: Q1 2026 in Review

Transcend Capital Advisors reduced its Eli Lilly (LLY) stake by 25% in Q1 2026, selling an estimated $2.39M and leaving 6,930 shares worth $6.37M. The position accounts for 0.51% of the portfolio, ranked #38.

Transcend Capital Advisors first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $15.3M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Transcend Capital Advisors held 6,930 shares of Eli Lilly worth $6.37M as of Q1 2026.
  • Transcend Capital Advisors sold 2,353 Eli Lilly shares in Q1 2026, an estimated $2.39M.
  • Eli Lilly made up 0.51% of Transcend Capital Advisors's portfolio in Q1 2026, its #38 holding.
  • Transcend Capital Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • Transcend Capital Advisors's Eli Lilly position peaked at $15.3M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.